Multi-Omics Analysis of Tislelizumab Plus Nab-Paclitaxel and Cisplatin As Neoadjuvant Immunochemotherapy for Locally Advanced Hypopharyngeal Squamous Cell Carcinoma: A Prospective Single-Arm Phase 2 Trial
crossref(2024)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined